FDA Inspection
Kedrion Biopharma Inc.Kedrion Biopharma Inc. – FDA Inspection, Nov 16, 2018
Record Details
This FDA Inspection record concerns Kedrion Biopharma Inc., with an inspection on November 16, 2018, issued by the New York District Office, covering biologics.
View Company Profile
ID · b8e2cc2d-0f5f-43fb-9760-367882106354
Inspection Facts
- Inspection number
- 1079026
- FDA center
- Biologics
- Outcome
- Form 483 issued
Other FDA inspections of Kedrion Biopharma Inc.
6| Date | Classification | Office | Project area |
|---|---|---|---|
| March 27, 2024 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 25, 2021 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 29, 2018 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 29, 2014 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 2, 2012 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Kedrion Biopharma Inc.
- FDA Inspection 1231467 - 2024-03-27
- FDA Inspection 1148187 - 2021-06-25
- FDA Inspection 1064655 - 2018-08-29
- FDA Inspection 900509 - 2014-09-29
- FDA Inspection 801013 - 2012-08-02
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.